323 related articles for article (PubMed ID: 30011807)
21. Noninvasive strategies for breast cancer early detection.
Trecate G; Sinues PM; Orlandi R
Future Oncol; 2016 Jun; 12(11):1395-411. PubMed ID: 27044539
[TBL] [Abstract][Full Text] [Related]
22. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
23. Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).
Díaz-Zaragoza M; Hernández-Ávila R; Viedma-Rodríguez R; Arenas-Aranda D; Ostoa-Saloma P
Oncol Rep; 2015 Sep; 34(3):1106-14. PubMed ID: 26133558
[TBL] [Abstract][Full Text] [Related]
24. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.
Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E
Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250
[TBL] [Abstract][Full Text] [Related]
25. Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.
Wu HJ; Chu PY
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435254
[TBL] [Abstract][Full Text] [Related]
26. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
27. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis.
Kathrikolly T; Nair SN; Mathew A; Saxena PPU; Nair S
Syst Rev; 2022 Oct; 11(1):215. PubMed ID: 36210467
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies as biomarkers for breast cancer diagnosis and prognosis.
Yang R; Han Y; Yi W; Long Q
Front Immunol; 2022; 13():1035402. PubMed ID: 36451832
[TBL] [Abstract][Full Text] [Related]
29. An SPR based immunoassay for the sensitive detection of the soluble epithelial marker E-cadherin.
Vergara D; Bianco M; Pagano R; Priore P; Lunetti P; Guerra F; Bettini S; Carallo S; Zizzari A; Pitotti E; Giotta L; Capobianco L; Bucci C; Valli L; Maffia M; Arima V; Gaballo A
Nanomedicine; 2018 Oct; 14(7):1963-1971. PubMed ID: 29902526
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
Evans RL; Pottala JV; Nagata S; Egland KA
BMC Cancer; 2018 Jan; 18(1):119. PubMed ID: 29386014
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
32. [Serum autoantibodies profiling and early-stage cancer detection].
Desmetz C; Lacombe J; Mange A; Maudelonde T; Solassol J
Med Sci (Paris); 2011; 27(6-7):633-8. PubMed ID: 21718648
[TBL] [Abstract][Full Text] [Related]
33. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches.
Yadav S; Kashaninejad N; Masud MK; Yamauchi Y; Nguyen NT; Shiddiky MJA
Biosens Bioelectron; 2019 Aug; 139():111315. PubMed ID: 31132724
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
[TBL] [Abstract][Full Text] [Related]
36. Serologic autoantibodies as diagnostic cancer biomarkers--a review.
Zaenker P; Ziman MR
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2161-81. PubMed ID: 24057574
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.
Madrid FF; Maroun MC; Olivero OA; Long M; Stark A; Grossman LI; Binder W; Dong J; Burke M; Nathanson SD; Zarbo R; Chitale D; Zeballos-Chávez R; Peebles C
BMC Cancer; 2015 May; 15():407. PubMed ID: 25975273
[TBL] [Abstract][Full Text] [Related]
38. Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer.
Liu X; Yu H; Qiao Y; Yang J; Shu J; Zhang J; Zhang Z; He J; Li Z
EBioMedicine; 2018 Feb; 28():70-79. PubMed ID: 29402727
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies: Opportunities for Early Cancer Detection.
Macdonald IK; Parsy-Kowalska CB; Chapman CJ
Trends Cancer; 2017 Mar; 3(3):198-213. PubMed ID: 28718432
[TBL] [Abstract][Full Text] [Related]
40. Blood-based protein biomarkers in breast cancer.
Núñez C
Clin Chim Acta; 2019 Mar; 490():113-127. PubMed ID: 30597138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
